Published in Diabetes Care on November 27, 2012
Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening Programme. Br J Ophthalmol (2014) 0.96
A prospective cross-sectional study on quality of life and treatment satisfaction in type 2 diabetic patients with retinopathy without other major late diabetic complications. Health Qual Life Outcomes (2014) 0.91
Risk for end-stage renal disease over 25 years in the population-based WESDR cohort. Diabetes Care (2013) 0.86
Changes observed in diabetic retinopathy: eight-year follow-up of a Spanish population. Br J Ophthalmol (2016) 0.80
Further insight on the limits of success of glycemic control in type 1 diabetes. Diabetes (2015) 0.78
Longitudinal Analysis of Adiponectin through 20-Year Type 1 Diabetes Duration. J Diabetes Res (2015) 0.75
Retrospective analysis of newly recorded certifications of visual impairment due to diabetic retinopathy in Wales during 2007-2015. BMJ Open (2017) 0.75
Differences in incidence of diabetic retinopathy between type 1 and 2 diabetes mellitus: a nine-year follow-up study. Br J Ophthalmol (2017) 0.75
The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol (1986) 124.55
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56
The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol (1984) 9.28
Incidence of diabetes in youth in the United States. JAMA (2007) 8.70
Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care (2012) 7.83
Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med (2009) 6.75
Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA (2010) 4.41
The hypertension detection and follow-up program: Hypertension detection and follow-up program cooperative group. Prev Med (1976) 3.57
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology (2008) 3.37
A comparison of the study populations in the Diabetes Control and Complications Trial and the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med (1995) 3.17
Diabetic retinopathy study. Report Number 6. Design, methods, and baseline results. Report Number 7. A modification of the Airlie House classification of diabetic retinopathy. Prepared by the Diabetic Retinopathy. Invest Ophthalmol Vis Sci (1981) 3.15
Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care (2003) 3.12
Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes (1990) 3.07
Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial. Diabetes Care (2007) 2.01
Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ (1996) 2.00
Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes-the Linköping Diabetes Complications Study. Diabetologia (2004) 1.92
The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology (2009) 1.87
Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. Diabetes (2010) 1.73
Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int (2002) 1.62
Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis. Diabetes Care (2009) 1.55
Lower-than-expected prevalence and severity of retinopathy in an incident cohort followed during the first 4-14 years of type 1 diabetes: the Wisconsin Diabetes Registry Study. Am J Epidemiol (2006) 1.34
Long-term impact of retinal screening on significant diabetes-related visual impairment in the working age population. Diabet Med (2009) 1.29
Diabetic retinopathy in type 1 diabetes-a contemporary analysis of 8,784 patients. Diabetologia (2011) 1.25
Health care expenditure burdens among adults with diabetes in 2001. Med Care (2006) 1.25
Are individuals with diabetes seeing better?: a long-term epidemiological perspective. Diabetes (2010) 1.23
Associations between socioeconomic status and major complications in type 1 diabetes: the Pittsburgh epidemiology of diabetes complication (EDC) Study. Ann Epidemiol (2011) 1.21
Risk factors for hospitalization in a cohort with type 1 diabetes. Wisconsin Diabetes Registry. Am J Epidemiol (1997) 1.08
Are obesity and anthropometry risk factors for diabetic retinopathy? The diabetes management project. Invest Ophthalmol Vis Sci (2011) 1.07
Longitudinal patterns of glycemic control and diabetes care from diagnosis in a population-based cohort with type 1 diabetes. The Wisconsin Diabetes Registry. Am J Epidemiol (1996) 1.01
Continued reduction in the prevalence of retinopathy in adolescents with type 1 diabetes: role of insulin therapy and glycemic control. Diabetes Care (2011) 1.00
Low cumulative incidence of proliferative retinopathy in childhood-onset type 1 diabetes: a 24-year follow-up study. Diabetologia (2006) 0.97
Prevalence and 25 year incidence of proliferative retinopathy among Danish type 1 diabetic patients. Diabetologia (2009) 0.94
Managing type 1 diabetes: trends and outcomes over 20 years in the Wisconsin Diabetes Registry cohort. WMJ (2009) 0.91
Diabetic retinopathy in 2011: further insights from new epidemiological studies and clinical trials. Diabetes Care (2011) 0.86
Incidence of retinopathy and associated risk factors from time of diagnosis of insulin-dependent diabetes. Arch Ophthalmol (1997) 0.86
Importance of the NHANES 2005-2008 diabetic retinopathy data. Arch Ophthalmol (2011) 0.79
Summary of current diabetes-related data from the National Center for Health Statistics. Diabetes Care (1980) 0.78
Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol (2004) 13.78
Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care (2012) 7.83
Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol (2013) 7.31
Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med (2009) 6.75
The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol (2004) 6.53
Diabetic retinopathy. N Engl J Med (2012) 5.79
Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol (2006) 4.68
The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol (2005) 4.46
Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA (2010) 4.41
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A (2010) 4.30
Retinopathy in diabetes. Diabetes Care (2004) 4.25
Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology (2007) 3.96
The impact of hearing loss on quality of life in older adults. Gerontologist (2003) 3.87
Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81
Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. Ophthalmology (2002) 3.80
Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch Ophthalmol (2004) 3.78
A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol (2005) 3.74
US norms for six generic health-related quality-of-life indexes from the National Health Measurement study. Med Care (2007) 3.56
Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology (2004) 3.53
Revised formulas for summarizing retinal vessel diameters. Curr Eye Res (2003) 3.47
Prevalence of olfactory impairment in older adults. JAMA (2002) 3.46
Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet (2008) 3.42
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology (2008) 3.37
Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology (2005) 3.28
Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. Arch Ophthalmol (2003) 3.17
The 5-year incidence and progression of hearing loss: the epidemiology of hearing loss study. Arch Otolaryngol Head Neck Surg (2003) 3.17
The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes (2006) 3.00
Diabetic retinopathy. Diabetes Care (2004) 2.97
Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology (2006) 2.95
Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. Am J Hum Genet (2003) 2.92
The economic burden of major adult visual disorders in the United States. Arch Ophthalmol (2006) 2.92
The association among smoking, heavy drinking, and chronic kidney disease. Am J Epidemiol (2006) 2.89
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. Lancet (2008) 2.89
Prevalence of age-related macular degeneration in the US population. Arch Ophthalmol (2011) 2.89
Retinal vascular caliber and the development of hypertension: a meta-analysis of individual participant data. J Hypertens (2014) 2.83
Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of atherosclerosis (MESA). Invest Ophthalmol Vis Sci (2006) 2.79
Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study. JAMA (2002) 2.78
Changes in visual acuity in a population over a 15-year period: the Beaver Dam Eye Study. Am J Ophthalmol (2006) 2.77
Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA (2002) 2.72
Long-term use of aspirin and age-related macular degeneration. JAMA (2012) 2.72
Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care (2002) 2.70
The Los Angeles Latino Eye Study: design, methods, and baseline data. Ophthalmology (2004) 2.68
Detection of age-related macular degeneration using a nonmydriatic digital camera and a standard film fundus camera. Arch Ophthalmol (2004) 2.67
ACE-I and ARBs in early diabetic nephropathy. J Renin Angiotensin Aldosterone Syst (2002) 2.64
Quantitative retinal venular caliber and risk of cardiovascular disease in older persons: the cardiovascular health study. Arch Intern Med (2006) 2.60
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials. Lancet (2008) 2.49
The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology (2003) 2.49
The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology (2007) 2.46
Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia. Nat Genet (2013) 2.36
The prevalence and risk factors of retinal microvascular abnormalities in older persons: The Cardiovascular Health Study. Ophthalmology (2003) 2.36
Meta-analysis of genome scans of age-related macular degeneration. Hum Mol Genet (2005) 2.34
Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye Study: methodology, correlation between eyes, and effect of refractive errors. Ophthalmology (2004) 2.26
The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. Arch Ophthalmol (2008) 2.24
Generational differences in the prevalence of hearing impairment in older adults. Am J Epidemiol (2009) 2.18
Retinal arteriolar diameter and risk for hypertension. Ann Intern Med (2004) 2.18
Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height. Am J Hum Genet (2010) 2.15
Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials. Ann Intern Med (2009) 2.14
Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study. Ophthalmology (2004) 2.12
Prospective cohort study of retinal vessel diameters and risk of hypertension. BMJ (2004) 2.10
Low birthweight is associated with narrower arterioles in adults. Hypertension (2008) 2.08
Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: Implications for diabetes diagnostic thresholds. Diabetes Care (2009) 2.08
Age-related macular degeneration and risk for stroke. Ann Intern Med (2006) 2.07
Retinal vessel caliber and microvascular and macrovascular disease in type 2 diabetes: XXI: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology (2007) 2.07
Burden of sleep apnea: rationale, design, and major findings of the Wisconsin Sleep Cohort study. WMJ (2009) 2.06
Retinal microvascular abnormalities and 10-year cardiovascular mortality: a population-based case-control study. Ophthalmology (2003) 2.04
Vision impairment and dual sensory problems in middle age. Ophthalmic Physiol Opt (2014) 2.04
The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy: XIX: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol (2004) 2.03